340B Nondiscrimination Act
Insurers, pharmacy benefit managers and other payers may not pay a 340B entity less for 340B drugs, set different terms or fees, require a 340B modifier on a claim or keep it out of a network. A manufacturer may not interfere with a 340B drug reaching a 340B entity or its contract pharmacy. A 340B entity contracts with any willing pharmacy within fifteen miles on terms both accept.
- In the code
- 36 O.S. 5400 to 5405
- Bill
- HB 2048
- Session
- 2025
- In effect
- 1 November 2025
- Applies to
- Health insurers, pharmacy benefit managers and other third-party payers; drug manufacturers; 340B entities
- Limits
- The payer rules do not apply to Oklahoma Medicaid as payer. Became law after the legislature overrode the Governor's veto.
- Enforcement
- The Insurance Department, for insurers, and the Attorney General, for others, may fine $100 to $10,000 for each violation.
A manufacturer shall not deny, restrict, prohibit, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to a 340B entity, unless such receipt is prohibited by the United States Department of Health and Human Services